A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with ( N ‐[ 11 C]methyl)benperidol
Synapse · 2013-11 · 67 (11) · 748-756
DOI: 10.1002/syn.21680 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Synapse, online erschienen am 30.05.2013. Verfasst von Sarah A Eisenstein und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, 63110. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Previous PET imaging studies have demonstrated mixed findings regarding dopamine D2/D3 receptor availability in obese relative to nonobese humans. Nonspecific D2/D3 radioligands do not allow for separate estimation of D2 receptor (D2R) and D3 receptor (D3R) subtypes of the D2 receptor family, which may play different roles in behavior and are distributed differently throughout the brain. These radioligands are also displaceable by endogenous dopamine, confounding interpretation of differences in receptor availability with differing levels of dopamine release. The present study used PET imaging with the D2R‐selective radioligand ( N ‐[ 11 C] methyl)benperidol ([ 11 C]NMB), which is nondisplaceable by endogenous dopamine, to estimate D2R specific binding (BP ND ) and its relationship to body mass index (BMI) and age in 15 normal‐weight (mean BMI = 22.6 kg/m 2 ) and 15 obese (mean BMI = 40.3 kg/m 2 ) men and women. Subjects with illnesses or taking medications that interfere with dopamine signaling were excluded. Striatal D2R BP ND was calculated using the Logan graphical method with cerebellum as a reference region. D2R BP ND estimates were higher in putamen and caudate relative to nucleus accumbens, but did not differ between normal‐weight and obese groups. BMI values did not correlate with D2R BP ND . Age was negatively correlated with putamen D2R BP ND in both groups. These results suggest that altered D2R specific binding is not involved in the pathogenesis of obesity per se and underscore the need for additional studies evaluating the relationship between D3R, dopamine reuptake, or endogenous dopamine release and human obesity. Synapse 67:748–756, 2013. . © 2013 Wiley Periodicals, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, 63110.
Förderung
- NIMH NIH HHS
- NIDDK NIH HHS
- NINDS NIH HHS
- NIDA NIH HHS
- NCATS NIH HHS
Zitieren
APA
Eisenstein, S. A., Antenor-Dorsey, J. A., Gredysa, D. M., Koller, J. M., Bihun, E. C., Ranck, S. A., Arbeláez, A. M., Klein, S., Perlmutter, J. S., Moerlein, S. M., Black, K. J., & Hershey, T. (2013). A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with ( N ‐[ 11 C]methyl)benperidol. Synapse, 67(11), 748-756. https://doi.org/10.1002/syn.21680
Vancouver
Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, et al. A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with ( N ‐[ 11 C]methyl)benperidol. Synapse. 2013;67(11):748-756. doi:10.1002/syn.21680
BibTeX
@article{Eisenstein2013,
author = {Eisenstein, Sarah A and Antenor-Dorsey, Jo Ann V and Gredysa, Danuta M and Koller, Jonathan M and Bihun, Emily C and Ranck, Samantha A and Arbeláez, Ana Maria and Klein, Samuel and Perlmutter, Joel S and Moerlein, Stephen M and Black, Kevin J and Hershey, Tamara},
title = {A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with ( N ‐[ 11 C]methyl)benperidol},
journal = {Synapse},
year = {2013},
volume = {67},
number = {11},
pages = {748--756},
doi = {10.1002/syn.21680}
}
EUVIMED